Search Login Register

Cyclophosphamide (Cytoxan) Summary

Description: Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.

Also Known As: Cytoxan; Neosar; B-518; Cyclophosphamide Monohydrate; Cyclophosphamide, (+-)-Isomer Show All >>

Networked: 15070 relevant articles (1657 outcomes, 2539 trials/studies) for this Drug

Key Diseases for which Cyclophosphamide is Relevant

  1. Neoplasms (Cancer) : 192 outcomes 374 studies in 2558 results
  2. Breast Neoplasms (Breast Cancer) : 170 outcomes 606 studies in 1723 results
  3. Non-Hodgkin Lymphoma (Lymphosarcoma) : 67 outcomes 127 studies in 531 results
  4. Lupus Nephritis : 58 outcomes 65 studies in 304 results
  5. Lymphoma (Lymphomas) : 56 outcomes 73 studies in 490 results
Show All >>

Drugs Related to Cyclophosphamide

  1. Doxorubicin (Adriamycin)
  2. Vincristine (Oncovin)
  3. Prednisone (Sone)
  4. Methotrexate (Mexate)
  5. Fluorouracil (Carac)
  6. Cisplatin (Platino)
  7. Etoposide (VP 16)
  8. Prednisolone (Predate)
  9. Adrenal Cortex Hormones (Corticosteroids)
  10. rituximab (Mabthera)
Show All >>

Therapies Related to Cyclophosphamide

  1. Drug Therapy (Chemotherapy)
  2. Combination Drug Therapy (Combination Chemotherapy)
  3. Bone Marrow Transplantation (Transplantation, Bone Marrow)
  4. Adjuvant Chemotherapy
  5. Transplants (Transplant)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2010 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.